XJPX
6951
Market cap2.19bUSD
Jul 10, Last price
7,874.00JPY
1D
7.73%
1Q
25.16%
Jan 2017
671.96%
Name
JEOL Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
JEOL Ltd. is a Japanese company that focuses on the research, development, manufacturing, and global sales of advanced high-technology equipment. Their products serve scientific, metrology (measurement), semiconductor, industrial, and medical industries. Their extensive product portfolio includes cutting-edge electron microscopes (both transmission and scanning types), as well as ion beam systems used for specimen preparation and multi-beam applications. They also offer a wide range of instruments for precise microarea and surface analysis, such as electron probe micro analyzers, Auger microprobes, and photoelectron spectrometers. Further offerings include sophisticated magnetic resonance equipment (like NMR and ESR spectrometers), X-ray fluorescence and mass spectrometers, electron beam lithography systems, and clinical chemistry analyzers. In addition to these analytical and scientific instruments, JEOL provides industrial solutions, particularly equipment for thin-film formation and various material processing tasks. The company also supports its products through processing, maintenance, and related services for parts and equipment, alongside the procurement and sale of peripheral devices. Founded in 1949, the company was initially named Japan Electron Optics Laboratory Co., Ltd. before officially rebranding to JEOL Ltd. in 1961. Its headquarters are situated in Akishima, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||